J. Anderson

发表

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)

H. May, T. Bunch, M. Cutler, 2022, Journal of arrhythmia.

An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction

B. Horne, J. Carlquist, J. Muhlestein, 2010, Journal of Thrombosis and Thrombolysis.

Genetic variants associated with syncope implicate neural and autonomic processes.

Hannes P. Eggertsson, D. Gudbjartsson, T. Thorgeirsson, 2023, European heart journal.

Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy

R. Brugada, M. Quiñones, J. Durand, 2001, Circulation.

Interaction of Baseline Characteristics With The Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients With Myocardial Infarction: A Possible Explanation for Increased Mortality in the Cardiac Arrhythmia Suppression Trial (CAST)

A. Hallstrom, P. Carson, R. Henthorn, 1994, Circulation.

The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation

Michael Cutler, H. May, T. Bair, 2016, Journal of cardiovascular electrophysiology.

Serial Electrophysiologic Effects of Bretylium in Man and Their Correlation with Plasma Concentrations

B. Lucchesi, E. Patterson, H. Marshall, 1982, Journal of cardiovascular pharmacology.

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry

B. Horne, H. May, T. Bair, 2022, medRxiv.

TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study

L. Becker, J. Anderson, S. Sorensen, 1993, Circulation.

2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee.

L. Allen, S. Virani, Laxmi S. Mehta, 2022, Journal of the American College of Cardiology.

Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing

B. Horne, H. May, J. Carlquist, 2008, Journal of Thrombosis and Thrombolysis.

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

B. Horne, D. Lappé, J. Carlquist, 2006, Journal of Thrombosis and Thrombolysis.

Thrombolysis and Myocardial Salvage Results of Clinical Trials and the Animal Paradigm‐ Paradoxic or Predictable?

B. Gersh, Jeffrey L. Anderson, J. Anderson, 1993, Circulation.

Spontaneous Variability of Ventricular Ectopic Activity in Patients with Sustained Ventricular Tachycardia and in Survivors of Cardiac Arrest

Jeffrey L. Anderson, J. Mason, M. Anastasiou-Nana, 1998 .

Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.

T. Assimes, B. Horne, N. Samani, 2013, Journal of the American College of Cardiology.

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2023, Journal of clinical medicine.

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2022, Journal of clinical medicine.

Do Higher Plasma Omega-3 Levels Predispose to Prostate Cancer? Results from the Intermountain INSPIRE Biobank Registry

B. Horne, J. Carlquist, T. Bair, 2022 .

Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13‐21 and Potential Effect Modification by Smoking

W. Kraus, B. Horne, J. Carlquist, 2009, Annals of human genetics.

Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

A Strategy of Rapid Cardioversion Minimizes the Significance of Early Recurrent Atrial Tachyarrhythmias After Ablation for Atrial Fibrillation

H. May, D. Lappé, T. Bair, 2011, Journal of cardiovascular electrophysiology.

Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long‐Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation

B. Horne, H. May, D. Lappé, 2011, Journal of cardiovascular electrophysiology.

Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36.

B. Horne, J. Carlquist, J. Muhlestein, 2004, Atherosclerosis.

Association of the dispersion in red blood cell volume with mortality

B. Horne, H. May, J. Muhlestein, 2015, European journal of clinical investigation.

Reassessment of Benefit—Risk Ratio and Treatment Algorithms for Antiarrhythmic Drug Therapy After the Cardiac Arrhythmia Suppression Trial

Jeffrey L. Anderson, J. Anderson, 1990, Journal of clinical pharmacology.

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial

B. Horne, H. May, T. Bair, 2021, Nutrients.

Genotype-Based Dosing Algorithms for Warfarin Therapy

B. Horne, J. Carlquist, Jeffrey L. Anderson, 2011, Molecular Diagnosis & Therapy.

The Disposition of Recainam Hydrochloride During and After Intravenous Loading and Maintenance Infusion in Cardiac Patients

D. Capuzzi, J. Anderson, M. Anastasiou-Nana, 1987, Journal of clinical pharmacology.